Dr. Biswa Mohan Sahoo is working as a professor at the School of Pharmacy and Life Sciences, Jatni, Bhubaneswar, Odisha. Dr. Sahoo completed his M.Pharm from L.M College of Pharmacy, Gujrat University, Ahmedabad, and PhD from the School of Pharmaceutical Education and Research, Berhampur University, Odisha. He has also completed his postgraduate diploma in Pharmaceutical Regulatory Affairs from Hamdard University, New Delhi. He has published several research and review articles in peer-reviewed journals of national and international repute. He has authored several textbooks of international repute. He has published 8 patents in India and Australia. Dr Sahoo is a recipient of the University Foundation Research Award-2019, 2022, and Startup Cell Award-2022, organized by BPUT, Rourkela, Odisha, Young Scientist Award by Indian Pharma Educational Society (IPES), Health Care Award-2018 by Venous International Foundation, Scientific Excellence Award-2018 by Marina Laboratory.
EDUCATION
B. Pharm. Degree in the year 2005 from Berhampur University, Berhampur, Odisha, India.
Master degree from Department of Medicinal Chemistry, L.M College of Pharmacy, Gujarat, India.
Doctor of Pharmacy from School of Pharmaceutical Education and Research (SPER), Berhampur University, India in 2013.
RESEARCH, TEACHING, or OTHER INTERESTS
Pharmaceutical Science, Drug Discovery, Chemistry, Pharmacology, Toxicology and Pharmaceutics
115
Scopus Publications
2279
Scholar Citations
22
Scholar h-index
42
Scholar i10-index
Scopus Publications
PHYTOCHEMICAL SCREENING AND EVALUATION OF ANTIUROLITHIATIC ACTIVITY OF Curcuma caesia RHIZOME EXTRACT S. K Sahoo, B. M Sahoo, A Nanda, B Singh Rasayan Journal of Chemistry, 2026 The crystallisation of minerals in the urinary tract is a major cause of kidney stone formation, also knownasurolithiasis. It is characterised by the formation of stones, also known as calculi or uroliths, within the urinary tract. These stones may accumulate in the bladder, urethra, ureters, or kidneys, resulting in several symptoms withpotential complications. Kidney stones can cause severe discomfort, blood in the urine, nausea, vomiting, fever, andchills. Treatment of urolithiasis depends on the size, location, and content of the stones, as well as the degreeof signs and symptoms. The primary objectives of the management are to relieve pain, enable stone passage, prevent recurrence, and protect kidney function. So, plant-based treatments are frequently used for the management of urolithiasis in traditional medicine. Curcuma caesia, also referred to as black turmeric, is well-known for itsantiurolithiatic property in traditional medicine. The high levels of flavonoids, phenols, and other antioxidant phytochemicals in Curcuma caesia are mainly responsible for its anti-urolithiasis effects. The rhizomes of Curcumacaesia were collected, dried, powered and extracted with ethanol using a Soxhlet apparatus. The presence of chemical constituents in Curcuma caesia was identified and characterised by phytochemical screening and spectral studies. Further, the antiurolithiatic property of Curcuma caesia was assessed through an in vitro study. Theevaluation results revealed that the ethanolic extract of Curcuma caesia exhibited promising antiurolithiatic activityin comparison with the marketed formulation (Cystone).
Overview of Nutritional Value and Pharmacological Properties of Millets Pratit Kanchan Sahu, Shyamalendu Tripathy, Sujit Kumar Martha, Diptimayee Jena, Kirtimaya Mishra, Ashirbad Nanda, Biswa Mohan Sahoo Journal of Natural Remedies, 2026 Background: Millets are small grains grown in arid climates and are rich in minerals, vitamins, and phytochemicals, making them highly nutritious. Their nutritional profile, which includes vitamins, dietary fibre, protein, and antioxidants, supports health and helps prevent disease. Aim: Millets are beneficial for managing lifestyle diseases because of their therapeutic properties, which include anti-diabetic, anti-inflammatory, antioxidant, and anti-Alzheimer’s agent properties. Methods: Additionally, their low glycemic index, gluten-free status, and ability to tolerate a variety of climates make them ideal for a range of nutritional needs and environmental sustainability. Results: The polyphenolic content of millets, namely finger millet, highlights their pharmacological potential by exhibiting antibacterial, antioxidant, and anti-diabetic properties. Conclusion: More research and studies into the use of millets in the food and pharmaceutical industries are necessary to fully realise their potential as nutrient-rich crops with significant health benefits. Major Findings:Millets, known for their high nutritional value of proteins, dietary fibres, vitamins, and minerals, are also valuable substances for improving human health and well-being. This study also reports the effects of millets on intestinal health and their possible future contributions to sustainability and global food security
Role of Nanotechnology for Targeted Therapy in Cancer Subhashree Pramanik, Biswa Mohan Sahoo, Sidhartha Parida, Nageswar Panda Current Nanomaterials, 2026 Nanotechnology plays a vital role in the development of targeted cancer therapies, offering the potential for more effective, accurate, and minimally invasive options for treatment. In order to improve drug accumulation within cancer cells and reduce exposure to healthy tissues, nanoparticles can be designed to deliver anticancer medications directly to the site of action. This targeted drug delivery increases the therapeutic efficacy and reduces systemic side effects. Compared to traditional therapies, nanocarriers are more effective at reaching tumor microenvironments and overcoming biological barriers due to their small size (between 1 and 100 nanometers). Nanoparticles can be loaded with a variety of agents, including chemotherapeutic agents, imaging agents, and photosensitizers, which allow for the combination of drug therapies and real-time therapy efficacy assessment. In addition to delivering drugs intracellularly, nanocarriers can also avoid drug efflux processes and can help some malignancies overcome resistance. This technology ensures localized drug therapy activation by enabling the design of nanocarriers that deliver drugs in response to specific stimuli inside the tumor microenvironment, such as temperature, enzymes, or acidic pH. With the help of nanotechnology, it is possible to develop theranostics that integrate both therapy and diagnostic imaging which enable real-time evaluation of therapeutic results and personalized treatment plans. Therefore, nanotechnology enhances the efficacy, safety, and customization of cancer treatment by enabling focused therapy, minimizing side effects, and incorporating diagnostic capabilities. These nanoplatforms are being optimized for clinical translation and better patient outcomes through ongoing research.
Microwave-assisted Green Extraction of Flavonoids: An Approach for the Development of Antiepileptic Agents Dipika Rani Sahu, Biswa Mohan Sahoo, Prafulla Nandi, Chandan Kumar Brahma, Ashirbad Nanda Current Drug Research Reviews, 2026 Herbal medicine has been used since ancient times for the treatment of various diseases and the improvement of human health. In research, the extraction process serves as a critical initial step for isolating and purifying key bioactive components from crude plant extracts. Despite its importance, the extraction stage often receives less attention and remains underexplored. In India, traditional techniques, such as maceration, Soxhlet extraction, steam distillation, and cold pressing, are still widely used for processing medicinal plants. However, these conventional methods suffer from limitations, including low selectivity, reduced yields, prolonged processing times, and significant environmental and safety concerns due to the extensive use of organic solvents. To address these challenges, innovative extraction techniques have emerged in recent years, offering greater efficiency, selectivity, and environmental sustainability. Notable advancements include Microwave-Assisted Extraction (MAE), Supercritical Fluid Extraction (SCFE), Accelerated Solvent Extraction (ASE), Subcritical Water Extraction (SWE), and Ultrasound-Assisted Extraction (USE). Among these, MAE has garnered significant attention for its potential to optimize extraction efficiency while minimizing resource consumption. This review provides a comprehensive comparison of different extraction methods, with a particular focus on the benefits of MAE. Furthermore, it explores the application of MAE-extracted flavonoids in the treatment of epilepsy, leveraging their proven ability to eliminate free radicals effectively. It also aims to highlight the advantages of adopting MAE in therapeutic contexts, offering novel insights into its role in enhancing the efficacy of flavonoid-based interventions. This work underscores the critical need for advancing extraction technologies to meet modern safety, environmental, and therapeutic demands.
Phytochemicals as Promising Therapeutics in Cancer Prevention and Treatment: Mechanisms and Applications Hrudesh Priyadarsan Sahoo, Ranjan Kumar Sahoo, Sidhartha Parida, Biswa Mohan Sahoo, Monalisa Gochhi, Priyanka Dash, Chandan das, Goutam Ghosh, Goutam Rath, Biswakanth Kar Current Cancer Drug Targets, 2026 Cancer remains a major cause of global morbidity and mortality, with rising inci-dence and limited effectiveness of conventional therapies due to systemic toxicity, adverse effects, and multidrug resistance. These limitations underscore the need for safer, targeted, and biologically effective therapeutic alternatives. Phytochemicals, naturally occurring compounds such as flavonoids, alkaloids, terpenoids, and polyphenols, have garnered consider-able attention due to their broad-spectrum anticancer activities and favorable safety profiles. This review assesses the therapeutic potential of phytochemicals in cancer prevention and treatment, focusing on their molecular mechanisms, pharmacological relevance, and translational applications. A comprehensive literature survey of peer-reviewed articles, clinical studies, and database reports (2015–2025) was conducted using PubMed, Scopus, Science Direct, and Web of Science with search terms including “phytochemicals,” “plant-derived compound”, “cancer”, “tumor”, “anticancer activity,” “molecular mechanisms,” “chemopre-vention,” “combination therapy,” and “chemotherapy” with Boolean operators. Phytochem-icals demonstrated significant anticancer effects by inhibiting cell proliferation, inducing apoptosis, suppressing angiogenesis, and modulating key oncogenic pathways, such as PI3K/Akt/mTOR, MAPK/ERK, and NF-κB. Clinically approved phytochemical-based drugs, including paclitaxel and vinblastine, validate their therapeutic relevance, while compounds such as curcumin and resveratrol show encouraging outcomes in ongoing studies. Synergistic interactions with conventional chemotherapeutics further enhance their therapeutic potential. Overall, phytochemicals exert multi-targeted actions regulating oxidative stress, inflammation, and cell survival pathways, offering advantages of reduced toxicity and enhanced efficacy. However, challenges such as poor solubility and low bioavailability limit their clinical translation. Continued efforts toward advanced formulations and robust clinical validation are essential to advance their integration into modern cancer therapeutics.
Recent Trends of Kinase Inhibitors in Cancer Therapy Nageswar Panda, Annanya Gangopadhyay, Biswa Mohan Sahoo Current Drug Research Reviews, 2025 Since 2000, significant changes have occurred in the cancer therapy landscape, and patient outcomes have also improved. Monoclonal antibodies and their derivatives, such as peptides and nanobodies, are examples of kinase-targeted strategies. Other novel approaches, such as the use of protein kinase interaction inhibitors and kinase degraders, have recently shown promise in treating resistance and have demonstrated encouraging results in clinical trials. Significant challenges confront kinase-targeted therapies, including drug resistance that severely reduces the clinical advantages for cancer patients and toxicity when paired with immunotherapy, which limits the full use of existing treatment modalities. The anti-angiogenic effect results in thrombotic microangiopathy-like lesions confined to the glomerulus through endothelial injury. Additionally, the glomerular tuft has segmental hyalinosis. By inhibiting VEGF receptors and the subsequent signaling, small compounds like Tyrosine Kinase Inhibitors (TKIs), such as pazopanib, can harm the endothelium and cause podocytopathy. A small modification of TKI-induced renal issues is linked to focal segmental glomerulosclerosis and nephrotic syndrome. A new kind of immunotherapy used against cancer is immune checkpoint inhibitors, which include PD-1, CTLA-4, and PD-L1. This review involves the study of recent advancements in potential novel targets and therapeutically relevant kinase inhibition techniques. This study focuses on the present issues and future prospects of kinase inhibitors in cancer therapy.
Current Insights into Polymeric Nanocarriers for Delivery of Phytomedicines in Breast Cancer Therapy Dipthi Shree, Chinam Niranjan Patra, Biswa Mohan Sahoo Current Nanomaterials, 2025 Background and Objectives: Globally, breast cancer is the most prevalent malignant disease that affects females and is one of the major causes of cancer-related death for women. The first line of treatment for breast cancer consists of chemotherapy drugs combined with radiation and surgical intervention. However, because therapeutic agents do not yet reach the tumor site at sufficient concentrations, resulting in decreased pharmacokinetics and increased systemic adverse effects, pharmacotherapy has been altered. Chemotherapy for breast cancer is more effective and successful, and is less toxic when nanotechnology is employed. Many cancer forms develop multidrug resistance, which appears to be a critical factor in the failure of numerous chemotherapy treatment classes. Phytofabricated nanoparticles have been developed recently for targeted herbal drug administration, molecular biology screening of biological markers for malignancies, and in vivo cancer diagnostics. Phytofabricated polymeric nanoparticles are the most prominent and emerging nanocarri-ers that have gained much research attention in the field of novel drug delivery systems for real-time treatment of breast cancer (BC) tumors. Methods: In herbal drug delivery technologies, the advancement of phytopharmacological science has led to the elucidation of the composition of phytoconstituents and their biological activities. Nano-sized herbal med-icines can overcome inadequate bioavailability, in vivo degradation and toxicity, uneven distribution, intesti-nal absorption, and a non-specific site of action. The combinatorial strategy of employing both nanotechnol-ogy and herbal medications allows for therapeutic potentiation, which reduces the required dose and undesir-able harmful effects. In the present study, a comprehensive search utilizes databases such as Google Scholar, PubMed, Embase, Scopus, Web of Science, etc, to locate the original research papers. In addition, diligent work is done to gather and update the progress of novel polymer-based nanocarriers for treating BC in the form of tables. Results: Researchers have devised innovative approaches to create and cultivate nanomedicine specifically targeted at breast cancer to attain even greater gains in drug resistance reversal, antitumorigenicity, antime-tastasis, and disease specificity. Nanoparticles' exceptionally high surface area-to-volume ratio makes it pos-sible to modify their surface characteristics for better therapeutic outcomes, i.e., cancer targeting, enhanced endocytosis and transcytosis, and extended circulation. This allows for more effective entry into tumor sites, metastasis, and cancer cells. Additionally, co-administration of phytochemical combinations may enhance additive or synergistic anticancer effects. Conclusion: Breast cancer treatment with phytofabricated polymeric nanoparticles appears to be a potential avenue of research. Furthermore, the utilization of phytofabricated polymeric nanoparticles in conjunction with other loaded phytoconstituents or chemotherapeutics demonstrated encouraging outcomes in the treat-ment of BC. This article depicts a comprehensive new finding that formulation scientists are developing on phytochemical-based polymeric nanocarriers to pave the way for future pharmaceutical nanotechnology re-search.
Current Perspective of Carbazole Scaffolds in Cancer Therapy Muskan Gupta, Shikha Sharma, Biswa Mohan Sahoo, Bimal Krishna Banik Current Bioactive Compounds, 2025 Cancer poses a significant threat to human life and well-being, resulting in numerous individuals suffering and succumbing to various forms of the disease each year. Considerable resources have been allocated to combat cancer, yet the limitations of existing anticancer agents, including their side effects and the development of drug resistance, have left substantial challenges in our quest to conquer cancer. Thus, there is an urgent necessity to discover and develop novel chemical compounds with the potential to inhibit cancer growth. In this review, we primarily focus on examining the effectiveness of two distinct classes of carbazole-based compounds: carboline derivatives and diazacarbazole derivatives. Diazacarbazole derivatives, a relatively unexplored area, hold promise for offering a fresh perspective and valuable opportunities to overcome the formidable obstacles in the ongoing battle against cancer. Additionally, we present several synthetic methods for creating the essential structural frameworks of carbazole-based tricyclic compounds.
Nano-based drug delivery of anticancer agents Biswa Mohan Sahoo, Dipthi Shree, Bimal Krishna Banik, Preetismita Borah, Adya Jain, Manoj Kumar Mahapatra Green Approaches in Medicinal Chemistry for Sustainable Drug Design Methods Second Edition, 2024
Computational approaches for development of anti-COVID-19 agents Biswa Mohan Sahoo, Bimal Krishna Banik, Preetismita Borah, Adya Jain, Abhishek Tiwari, Manoj Kumar Mahapatra Green Approaches in Medicinal Chemistry for Sustainable Drug Design Methods Second Edition, 2024
Quantum Dots: An Emerging Approach for Cancer Therapy Sheetal Devi, Manish Kumar, Abhishek Tiwari, Varsha Tiwari, Deepak Kaushik, Ravinder Verma, Shailendra Bhatt, Biswa Mohan Sahoo, Tanima Bhattacharya, Sultan Alshehri, Mohammed M. Ghoneim, Ahmad O. Babalghith, Gaber El-Saber Batiha Frontiers in Materials, 2022
New quinazolines: Synthesis, medicinal and pharmacological activities Organic and Medicinal Chemistry, 2018
Microwave-induced one-pot synthesis of pyrimidine-2(1H)-one derivatives as anti-inflammatory agents Journal of the Indian Chemical Society, 2018
Thermal and non-thermal effects of microwaves in synthesis Journal of the Indian Chemical Society, 2018
Microwave-assisted synthesis and evaluation of indole derivatives as potential anthelmintic agents Journal of the Indian Chemical Society, 2018
Microwave-assisted synthesis: Paradigm of green chemistry Journal of the Indian Chemical Society, 2018
Microwave-mediated Green synthesis of oxadiazole derivatives against inflammatory disease Journal of the Indian Chemical Society, 2018
Microwave-mediated Green chemistry approach for the synthesis of some chalcone derivatives and evaluation of their anthelmintic activity Journal of the Indian Chemical Society, 2018
Microwave-irradiated synthesis and biological evaluation of 3,5-diaryl-1-phenyl-2-pyrazolines as antibacterial and anti-inflammatory agents Journal of the Indian Chemical Society, 2018
Design, synthesis and antiepileptic evaluation of 5-(aryl)-n-phenyl-1,3,4-thiadiazol-2-amine International Journal of Pharmacy and Pharmaceutical Sciences, 2012
Synthesis and screening for antibacterial, analgesic and anti-inflammatory activity of Mannich bases derived from 1H-indole-2,3-dione Journal of the Indian Chemical Society, 2012
Microwave irradiation versus conventional method: Synthesis of benzimidazolyl chalcone derivatives International Journal of Chemtech Research, 2010
RECENT SCHOLAR PUBLICATIONS
Glycosylation in Cancer Medicines Delivery and Their Patents. BM Sahoo, S Sharma, P Bhatnagar, GK Saraogi, BK Banik Current Drug Delivery , 2026 2026
Regulatory Evolution of Biologics in India: Innovation Gaps and Strategic Imperatives for Global Leadership. A Panda, BM Sahoo, CK Brahma, HB Samal Current Drug Discovery Technologies , 2026 2026
Treatment outcomes and safety profile of SGLT2 inhibitors versus GLP-1 agonists in type 2 diabetes mellitus: Systematic review of real-world observational studies A Alam, M Imran, Z ur Rehman, BM Sahoo, MK Mahapatra Wiener Medizinische Wochenschrift 176 (1), 45-59 , 2026 2026
Redox Potential: A Key Player in Uranium Fate Y Ukwishaka, K Komal, AK Singh, M Kumar, BM Sahoo, P Singh, P Borah Water Quality-Uranium Solubility Nexus: Unlocking the Secrets of Uranium … , 2026 2026
Natural and Anthropogenic Factors: Shapers of Soluble Uranium Levels K Komal, A Kumar, Y Ukwishaka, S Ranjan, M Kumar, BM Sahoo, P Singh, ... Water Quality-Uranium Solubility Nexus: Unlocking the Secrets of Uranium … , 2026 2026 Citations: 1
Different Types of Nanocomposites Used in Biomedical Applications A Singh, S Yadav, NN Palei, M Roy, R Parhi, BM Sahoo, BC Mohanta Nanocomposites and Nanomaterials in Biomedical Applications, 39-84 , 2026 2026
Kinase Inhibitors: Synthesis, Medicinal Effects, and Applications BM Sahoo, MA Mir, BK Banik CRC Press , 2026 2026
Microwave-assisted Extraction: A Green and Sustainable Technology for the Extraction of Bioactive Compounds BM Sahoo, SK Bhattamisra, SK Paidesetty, NN Palei, S Sharma, ... Current Microwave Chemistry 12 (2), 105-115 , 2025 2025 Citations: 3
Development of sophisticated RP-HPLC approach for quantifying lornoxicam in API and pharmaceutical formulation BM Sahoo, CK Brahma, BR Jena, K Mishra, D Panda, SN Tripathy, ... Advancement in Animal Handling and Generative AI for Pre-clinical Studies … , 2025 2025
Microwave-assisted green synthesis: An approach for the development of anti-tubercular agents BM Sahoo, P Nandi, DR Sahu, BK Banik, S Sharma, B Chandrasekaran, ... Current Drug Targets 26 (10), 665-682 , 2025 2025 Citations: 3
Current Perspective of Carbazole Scaffolds in Cancer Therapy M Gupta, S Sharma, BM Sahoo, BK Banik Current Bioactive Compounds 21 (4), e050624230694 , 2025 2025
Microwave-assisted Green Extraction of Flavonoids: An Approach for the Development of Antiepileptic Agents DR Sahu, BM Sahoo, P Nandi, CK Brahma, A Nanda Current Drug Research Reviews , 2025 2025
Influence of Orange Oil on Skin Permeability, Dermatokinetics, and In Vivo Anti-inflammatory Properties of Lornoxicam-loaded Niosomal Gel NN Palei, AK Dhar, J Rajangam, D Prasad P, BM Sahoo Current Drug Metabolism 26 (3), 208-223 , 2025 2025
Current insights into therapeutic potential of terpenoids as anticancer agents BM Sahoo, BK Banik, S Sharma, B Singh Anti-Cancer Agents in Medicinal Chemistry 25 (5), 339-356 , 2025 2025 Citations: 10
Validated RP-HPLC Method for Simultaneous Estimation of Tadalafil and Macitentan in Bulk and Dosage Forms BM Sahoo, PV Rao, NS Rao, KB Lakshmi, NR Babu, D Panda, ... Current Spectroscopy and Chromatography 11 (1), E29504910393905 , 2025 2025
Recent Trends of Kinase Inhibitors in Cancer Therapy N Panda, A Gangopadhyay, BM Sahoo Current Drug Research Reviews , 2025 2025
Current Insights into Polymeric Nanocarriers for Delivery of Phytomedicines in Breast Cancer Therapy D Shree, CN Patra, BM Sahoo Current Nanomaterials , 2025 2025 Citations: 2
A Comprehensive Review on Current Microwave Chemistry KC Panda, BVVR Kumar, S Jammula, BM Sahoo Current Microwave Chemistry , 2025 2025 Citations: 2
Novel Drug Targets in Neuro-immune Disorders B Gorain, V Karmakar, M Pandey, Pooja, BM Sahoo, D Senapati, ... Advances in Immunology and Immuno-techniques: Updated Concepts and Recent … , 2024 2024
Emerging Nanoparticle-Based Herbal Drug Delivery Systems for Colon Targeting Therapy D Shree, CN Patra, BM Sahoo Internat Journal of Gastroent and Hepatology Diseases , 2024 2024 Citations: 3
MOST CITED SCHOLAR PUBLICATIONS
Reactive Oxygen Species (ROS): Key components in Cancer Therapies BM Sahoo, BK Banik, P Borah, A Jain Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal … , 2022 2022 Citations: 355
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes MK Mahapatra, M Karuppasamy, BM Sahoo Reviews in Endocrine and Metabolic Disorders 23 (3), 521-539 , 2022 2022 Citations: 220
Polyaromatic hydrocarbons (PAHs): structures, synthesis and their biological profile BM Sahoo, BVV Ravi Kumar, BK Banik, P Borah Current Organic Synthesis 17 (8), 625-640 , 2020 2020 Citations: 167
Drug repurposing strategy (DRS): Emerging approach to identify potential therapeutics for treatment of novel coronavirus infection BM Sahoo, BVV Ravi Kumar, J Sruti, MK Mahapatra, BK Banik, P Borah Frontiers in Molecular Biosciences 8, 628144 , 2021 2021 Citations: 166
Quantum dots: An emerging approach for cancer therapy S Devi, M Kumar, A Tiwari, V Tiwari, D Kaushik, R Verma, S Bhatt, ... Frontiers in Materials 8, 798440 , 2022 2022 Citations: 139
Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review … MK Mahapatra, M Karuppasamy, BM Sahoo Pharmaceutical Research 39 (6), 1233-1248 , 2022 2022 Citations: 132
Green synthetic approach: An efficient eco-friendly tool for synthesis of biologically active oxadiazole derivatives BK Banik, BM Sahoo, BVVR Kumar, KC Panda, J Jena, MK Mahapatra, ... Molecules 26 (4), 1163 , 2021 2021 Citations: 69
Design, green synthesis, and anti-inflammatory activity of schiff base of 1, 3, 4-oxadiazole analogues B Mohan Sahoo, S Chandra Dinda, BVV Ravi Kumar, J Panda, ... Letters in Drug Design & Discovery 11 (1), 82-89 , 2014 2014 Citations: 51
Microwave-assisted synthesis, molecular docking and antitubercular activity of 1, 2, 3, 4-tetrahydropyrimidine-5-carbonitrile derivatives SB Mohan, BVVR Kumar, SC Dinda, D Naik, SP Seenivasan, V Kumar, ... Bioorganic & medicinal chemistry letters 22 (24), 7539-7542 , 2012 2012 Citations: 51
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review NK Jain, M Tailang, HK Jain, B Chandrasekaran, BM Sahoo, ... Frontiers in Pharmacology 14, 1135145 , 2023 2023 Citations: 38
Green expedient synthesis of pyrimidine derivatives via chalcones and evaluation of their anthelmintic activity BM Sahoo, M Rajeswari, P Jnyanaranjan, S Binayani Indian Journal of Pharmaceutical Education and Research 51 (4S), S700-S706 , 2017 2017 Citations: 38
Microwave assisted green synthesis of benzimidazole derivatives and evaluation of their anticonvulsant activity BM Sahoo, BK Banik, NS Rao, B Raju Current Microwave Chemistry 6 (1), 23-29 , 2019 2019 Citations: 36
Organocatalysis: Trends of Drug Synthesis in Medicinal Chemistry BM Sahoo, BK Banik Current Organocatalysis 6 (2), 14 , 2019 2019 Citations: 35
Microwave Induced Green Synthesis: Sustainable Technology for Efficient Development of Bioactive Pyrimidine Scaffolds BM Sahoo, BK Banik, BVVR Kumar, KC Panda, A Tiwari, V Tiwari, ... Current Medicinal Chemistry 30 (9), 1029 - 1059 , 2023 2023 Citations: 28
Anti-Cancer Agents Med BM Sahoo, BK Banik, P Borah, A Jain Chem 22, 215-222 , 2022 2022 Citations: 27
Microwave irradiation versus conventional method: synthesis of benzimidazolyl chalcone derivatives SB Mohan, TP Behera, BR Kumar International Journal of ChemTech Research 2 (3), 1634-1637 , 2010 2010 Citations: 27
Lipid based nanoparticles: Current strategies for brain tumor targeting BC Mohanta, NN Palei, V Surendran, SC Dinda, J Rajangam, J Deb, ... Current Nanomaterials 4 (2), 84-100 , 2019 2019 Citations: 26
Advances in microwave chemistry BK Banik, D Bandyopadhyay CRC Press , 2018 2018 Citations: 26
Solvent-less reactions: Green and sustainable approaches in medicinal chemistry BM Sahoo, BK Banik Green approaches in medicinal chemistry for sustainable drug design, 523-548 , 2020 2020 Citations: 25
Microwave-assisted synthesis: Paradigm of green chemistry AK Mahato, BM Sahoo, BK Banik, BC Mohanta J. Indian Chem. Soc 95 (11), 1327-1339 , 2018 2018 Citations: 25